John R. Prensner

21.2k total citations · 4 hit papers
43 papers, 7.3k citations indexed

About

John R. Prensner is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John R. Prensner has authored 43 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 26 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John R. Prensner's work include Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (12 papers) and Prostate Cancer Treatment and Research (10 papers). John R. Prensner is often cited by papers focused on Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (12 papers) and Prostate Cancer Treatment and Research (10 papers). John R. Prensner collaborates with scholars based in United States, Netherlands and Canada. John R. Prensner's co-authors include Arul M. Chinnaiyan, Xuhong Cao, Matthew K. Iyer, Saravana M. Dhanasekaran, Felix Y. Feng, John T. Wei, Anirban Sahu, Dan R. Robinson, Arul M. Chinnaiyan and Rohit Malik and has published in prestigious journals such as Cell, Nature Medicine and Nature Communications.

In The Last Decade

John R. Prensner

42 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The landscape of long noncoding RNAs in the human transcriptome

2015 2.1k citations Matthew K. Iyer, Yashar S. Niknafs et al. profile →
The Emergence of lncRNAs in Cancer Biology

2011 1.4k citations John R. Prensner, Arul M. Chinnaiyan profile →
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression

2011 815 citations John R. Prensner, Matthew K. Iyer et al. Nature Biotechnology profile →
Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer

2008 513 citations Scott A. Tomlins, Bharathi Laxman et al. Neoplasia profile →

Peers

John R. Prensner

PRM

ONCOL

EPIDE

Bharathi Laxman United States

Xiaojun Jing United States

Riccardo Spizzo Italy

Ping Wei China

Xiaoju Wang China

Satoko Kojima Japan

Xin Hu China

Eric J. Bernhard United States

Cathy D. Vocke United States

Robert J. Lonigro United States

Bharathi Laxman United States

John R. Prensner

4.5k ×0.8

2.6k ×0.5

2.4k ×1.7

PRM

769 ×1.4

ONCOL

196 ×0.6

EPIDE

Citations per year, relative to John R. Prensner John R. Prensner (= 1×) peers Bharathi Laxman

Countries citing papers authored by John R. Prensner

Since Specialization

Citations

This map shows the geographic impact of John R. Prensner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Prensner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Prensner more than expected).

Fields of papers citing papers by John R. Prensner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Prensner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Prensner. The network helps show where John R. Prensner may publish in the future.

Co-authorship network of co-authors of John R. Prensner

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Prensner. A scholar is included among the top collaborators of John R. Prensner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Prensner. John R. Prensner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gupta, Ramneek, et al.. (2025). Deep learning to decode sites of RNA translation in normal and cancerous tissues. Nature Communications. 16(1). 1275–1275. 5 indexed citations

Prensner, John R., et al.. (2024). Microproteins in cancer: identification, biological functions, and clinical implications. Trends in Genetics. 41(2). 146–161. 12 indexed citations

Prensner, John R., et al.. (2024). Upstream open reading frames: new players in the landscape of cancer gene regulation. NAR Cancer. 6(2). zcae023–zcae023. 7 indexed citations

Posner, Zoe, et al.. (2023). Shining a light on the dark proteome: Non‐canonical open reading frames and their encoded miniproteins as a new frontier in cancer biology. Protein Science. 32(8). e4708–e4708. 14 indexed citations

Prensner, John R., Jennifer G. Abelin, Karl R. Clauser, et al.. (2023). What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome?. Molecular & Cellular Proteomics. 22(9). 100631–100631. 46 indexed citations

Ruiz‐Orera, Jorge, Alexandra L. Condurat, Vignesh Shanmugam, et al.. (2023). MDB-32. TRANSLATION OF NON-CANONICAL OPEN READING FRAMES AS A CANCER CELL SURVIVAL MECHANISM IN CHILDHOOD MEDULLOBLASTOMA. Neuro-Oncology. 25(Supplement_1). i69–i69.

Wilkie, Gianna, et al.. (2018). Burkitt Lymphoma Presenting as Menorrhagia and a Vaginal Mass in an Adolescent. Journal of Pediatric and Adolescent Gynecology. 32(1). 90–92. 3 indexed citations

Balbin, O. Alejandro, Rohit Malik, Saravana M. Dhanasekaran, et al.. (2015). The landscape of antisense gene expression in human cancers. Genome Research. 25(7). 1068–1079. 129 indexed citations

Malik, Rohit, Lalit R. Patel, John R. Prensner, et al.. (2014). The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer. Molecular Cancer Research. 12(8). 1081–1087. 112 indexed citations

10.

Prensner, John R., Wei Chen, Sumin Han, et al.. (2014). The Long Non-Coding RNA PCAT-1 Promotes Prostate Cancer Cell Proliferation through cMyc. Neoplasia. 16(11). 900–908. 200 indexed citations

11.

Nadal, Ernest, Guoan Chen, John R. Prensner, et al.. (2014). KRAS-G12C Mutation Is Associated with Poor Outcome in Surgically Resected Lung Adenocarcinoma. Journal of Thoracic Oncology. 9(10). 1513–1522. 111 indexed citations

12.

Mehra, Rohit, Yang Shi, Aaron M. Udager, et al.. (2014). A Novel RNA In Situ Hybridization Assay for the Long Noncoding RNA SChLAP1 Predicts Poor Clinical Outcome After Radical Prostatectomy in Clinically Localized Prostate Cancer. Neoplasia. 16(12). 1121–1127. 72 indexed citations

13.

Prensner, John R., Shuang G. Zhao, Nicholas Erho, et al.. (2014). RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. The Lancet Oncology. 15(13). 1469–1480. 201 indexed citations

14.

Balbin, O. Alejandro, John R. Prensner, Anirban Sahu, et al.. (2013). Reconstructing targetable pathways in lung cancer by integrating diverse omics data. Nature Communications. 4(1). 2617–2617. 59 indexed citations

15.

Brenner, J. Chad, Felix Y. Feng, Sumin Han, et al.. (2012). PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma. Cancer Research. 72(7). 1608–1613. 206 indexed citations

16.

Prensner, John R., Arul M. Chinnaiyan, & Sudhir Srivastava. (2012). Systematic, evidence-based discovery of biomarkers at the NCI. Clinical & Experimental Metastasis. 29(7). 645–652. 16 indexed citations

17.

Prensner, John R., Guoan Chen, Qi Cao, et al.. (2009). An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer. Nature Biotechnology. 27(11). 1005–1011. 53 indexed citations

18.

Prensner, John R. & Arul M. Chinnaiyan. (2009). Oncogenic gene fusions in epithelial carcinomas. Current Opinion in Genetics & Development. 19(1). 82–91. 54 indexed citations

19.

Helgeson, Beth E., Scott A. Tomlins, Nameeta Shah, et al.. (2008). Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 Gene Fusions in Prostate Cancer. Cancer Research. 68(1). 73–80. 206 indexed citations

20.

Tomlins, Scott A., Bharathi Laxman, Sooryanarayana Varambally, et al.. (2008). Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer. Neoplasia. 10(2). 177–IN9. 513 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact